AAPP’s newest policy requests provide support to rescheduling cannabis and psychedelics to reduce barriers to rigorous clinical research with the goal to strengthen the evidence base on both benefit and harm. Please visit these policy asks and use them as the basis for advocacy in your city, state, and federally.